146 related articles for article (PubMed ID: 38363910)
1. Insight into deep learning for glioma IDH medical image analysis: A systematic review.
Lv Q; Liu Y; Sun Y; Wu M
Medicine (Baltimore); 2024 Feb; 103(7):e37150. PubMed ID: 38363910
[TBL] [Abstract][Full Text] [Related]
2. Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning.
Liu S; Shah Z; Sav A; Russo C; Berkovsky S; Qian Y; Coiera E; Di Ieva A
Sci Rep; 2020 May; 10(1):7733. PubMed ID: 32382048
[TBL] [Abstract][Full Text] [Related]
3. An Intra- and Inter-Modality Fusion Model Using MR Images for Prediction of Glioma Isocitrate Dehydrogenase (IDH) Mutation.
Shi X; Zhang X; Iwamoto Y; Cheng J; Bai J; Zhao G; Chen YW
Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():198-202. PubMed ID: 36086447
[TBL] [Abstract][Full Text] [Related]
4. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF
Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548
[TBL] [Abstract][Full Text] [Related]
5. Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging.
Cluceru J; Interian Y; Phillips JJ; Molinaro AM; Luks TL; Alcaide-Leon P; Olson MP; Nair D; LaFontaine M; Shai A; Chunduru P; Pedoia V; Villanueva-Meyer JE; Chang SM; Lupo JM
Neuro Oncol; 2022 Apr; 24(4):639-652. PubMed ID: 34653254
[TBL] [Abstract][Full Text] [Related]
6. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.
Zhou H; Chang K; Bai HX; Xiao B; Su C; Bi WL; Zhang PJ; Senders JT; Vallières M; Kavouridis VK; Boaro A; Arnaout O; Yang L; Huang RY
J Neurooncol; 2019 Apr; 142(2):299-307. PubMed ID: 30661193
[TBL] [Abstract][Full Text] [Related]
7. A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas.
Bangalore Yogananda CG; Shah BR; Vejdani-Jahromi M; Nalawade SS; Murugesan GK; Yu FF; Pinho MC; Wagner BC; Mickey B; Patel TR; Fei B; Madhuranthakam AJ; Maldjian JA
Neuro Oncol; 2020 Mar; 22(3):402-411. PubMed ID: 31637430
[TBL] [Abstract][Full Text] [Related]
8. Computational Pathology for Prediction of Isocitrate Dehydrogenase Gene Mutation from Whole Slide Images in Adult Patients with Diffuse Glioma.
Zhao Y; Wang W; Ji Y; Guo Y; Duan J; Liu X; Yan D; Liang D; Li W; Zhang Z; Li ZC
Am J Pathol; 2024 May; 194(5):747-758. PubMed ID: 38325551
[TBL] [Abstract][Full Text] [Related]
9. MRI-based deep learning techniques for the prediction of isocitrate dehydrogenase and 1p/19q status in grade 2-4 adult gliomas.
Kalaroopan D; Lasocki A
J Med Imaging Radiat Oncol; 2023 Aug; 67(5):492-498. PubMed ID: 36919468
[TBL] [Abstract][Full Text] [Related]
10. Multi-task Model for Glioma Segmentation and Isocitrate Dehydrogenase Status Prediction Using Global and Local Features.
Shi X; Li Y; Cheng J; Bai J; Zhao G; Chen YW
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-5. PubMed ID: 38083206
[TBL] [Abstract][Full Text] [Related]
11. Identification of IDH and TERTp mutations using dynamic susceptibility contrast MRI with deep learning in 162 gliomas.
Buz-Yalug B; Turhan G; Cetin AI; Dindar SS; Danyeli AE; Yakicier C; Pamir MN; Özduman K; Dincer A; Ozturk-Isik E
Eur J Radiol; 2024 Jan; 170():111257. PubMed ID: 38134710
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy and potential covariates for machine learning to identify IDH mutations in glioma patients: evidence from a meta-analysis.
Zhao J; Huang Y; Song Y; Xie D; Hu M; Qiu H; Chu J
Eur Radiol; 2020 Aug; 30(8):4664-4674. PubMed ID: 32193643
[TBL] [Abstract][Full Text] [Related]
13. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
14. World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
Maynard J; Okuchi S; Wastling S; Busaidi AA; Almossawi O; Mbatha W; Brandner S; Jaunmuktane Z; Koc AM; Mancini L; Jäger R; Thust S
Radiology; 2020 Jul; 296(1):111-121. PubMed ID: 32315266
[TBL] [Abstract][Full Text] [Related]
15. Prediction of IDH mutation status of glioma based on terahertz spectral data.
Sun Z; Wu X; Tao R; Zhang T; Liu X; Wang J; Wan H; Zheng S; Zhao X; Zhang Z; Yang P
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jul; 295():122629. PubMed ID: 36958244
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting.
Tietze A; Choi C; Mickey B; Maher EA; Parm Ulhøi B; Sangill R; Lassen-Ramshad Y; Lukacova S; Østergaard L; von Oettingen G
J Neurosurg; 2018 Feb; 128(2):391-398. PubMed ID: 28298040
[TBL] [Abstract][Full Text] [Related]
17. MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas.
Stadlbauer A; Zimmermann M; Kitzwögerer M; Oberndorfer S; Rössler K; Dörfler A; Buchfelder M; Heinz G
Radiology; 2017 Jun; 283(3):799-809. PubMed ID: 27982759
[TBL] [Abstract][Full Text] [Related]
18. Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics.
Choi YS; Bae S; Chang JH; Kang SG; Kim SH; Kim J; Rim TH; Choi SH; Jain R; Lee SK
Neuro Oncol; 2021 Feb; 23(2):304-313. PubMed ID: 32706862
[TBL] [Abstract][Full Text] [Related]
19. Radiogenomic association between the T2-FLAIR mismatch sign and IDH mutation status in adult patients with lower-grade gliomas: an updated systematic review and meta-analysis.
Han Z; Chen Q; Zhang L; Mo X; You J; Chen L; Fang J; Wang F; Jin Z; Zhang S; Zhang B
Eur Radiol; 2022 Aug; 32(8):5339-5352. PubMed ID: 35169897
[TBL] [Abstract][Full Text] [Related]
20. Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network.
Choi KS; Choi SH; Jeong B
Neuro Oncol; 2019 Sep; 21(9):1197-1209. PubMed ID: 31127834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
